<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-07T07:29:13Z</responseDate>
  <request identifier="oai:figshare.com:article/33346545" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/33346545</identifier>
        <datestamp>2026-09-22T09:21:02Z</datestamp>
        <setSpec>category_24631</setSpec>
        <setSpec>category_24778</setSpec>
        <setSpec>category_24787</setSpec>
        <setSpec>category_24799</setSpec>
        <setSpec>portal_886</setSpec>
        <setSpec>item_type_3</setSpec>
        <setSpec>month_year_09_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>&lt;b&gt;Supporting Data for Single and Combinational Immunotherapies to Overcome Isocitrate Dehydrogenase 1 Mutant Intrahepatic Cholangiocarcinoma&lt;/b&gt;</dc:title>
          <dc:creator>Xinqi Liu (13008900)</dc:creator>
          <dc:creator>Carmen Chak Lui Wong (9052118)</dc:creator>
          <dc:subject>Tumour immunology</dc:subject>
          <dc:subject>Cancer cell biology</dc:subject>
          <dc:subject>Cancer therapy (excl. chemotherapy and radiation therapy)</dc:subject>
          <dc:subject>Molecular targets</dc:subject>
          <dc:subject>Liver Cancer</dc:subject>
          <dc:subject>Cholangiocarcinoma</dc:subject>
          <dc:subject>Immunotherapy</dc:subject>
          <dc:subject>Targeted Therapy</dc:subject>
          <dc:subject>IDH1 Mutation</dc:subject>
          <dc:description>&lt;p dir="ltr"&gt;This dataset accompanies a study characterising the immune microenvironment of IDH1-mutant intrahepatic cholangiocarcinoma (iCCA). By investigating the impact of the oncometabolite R-2HG on primary murine cells, novel immunotherapeutic strategies for IDH1-mutant iCCA were identified. The repository contains quantitative IDH1 expression data from engineered murine iCCA cell lines, along with proliferation, apoptosis, Treg proportion, and transcriptomic sequencing data from T cells co-cultured with IDH1-mutant cells or treated with R-2HG. Additionally, data regarding the antigen presentation functionality of bone marrow-derived dendritic cells under R-2HG treatment, as well as tumour burden evaluations following STING agonist therapy, are included.&lt;/p&gt;</dc:description>
          <dc:date>2026-09-22T09:21:02Z</dc:date>
          <dc:type>Dataset</dc:type>
          <dc:type>Dataset</dc:type>
          <dc:identifier>10.25442/hku.33346545.v1</dc:identifier>
          <dc:relation>https://figshare.com/articles/dataset/_b_Supporting_Data_for_Single_and_Combinational_Immunotherapies_to_Overcome_Isocitrate_Dehydrogenase_1_Mutant_Intrahepatic_Cholangiocarcinoma_b_/33346545</dc:relation>
          <dc:rights>CC BY-NC 4.0</dc:rights>
          <dc:rights>Embargoed</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
